Please login to the form below
Cell Therapeutics Inc
This page shows the latest Cell Therapeutics Inc news and features for those working in and with pharma, biotech and healthcare.
CTI launches cancer drug Pixuvri in UK
Now available to treat form of non-Hodgkin lymphoma. Cell Therapeutics Inc (CTI) has launched its cancer treatment Pixuvri in the UK. ... Pixuvri (pixantrone) becomes the first drug available in the UK as a monotherapy treatment option for adults with
Latest news
-
Baxter licenses cancer drug from CTI in $172m deal
Pacritinib is being investigated to treat blood disorder myelofibrosis. Cell Therapeutics Inc (CTI) has met its objective of finding a commercial partner for cancer candidate pacritinib by the end of the
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2016
licence, collaboration expanded. 830. Adaptimmune Therapeutics/ GSK. TCR engineered T-cell therapies inc affinity enhanced T-cell immunotherapy targeting NY-ESO-1 (p1/2); 4 other progs and combination studies. ... acquisition - product. 190. Annapurna
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Lilly’s Verzenio scores a win in early-stage breast cancer
- New study identifies drugs that are safe to use in COVID-19 treatment
- Researchers call on Pfizer to delay COVID-19 vaccine application
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Phase 1/2a results for J&J’s COVID-19 vaccine show early promise
- J&J advances COVID-19 vaccine into phase 3 testing
- Covid-19 redefines rules of customer engagement
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Aurora extends exclusive collaboration with Patient Intelligence Panel (PIP Health)
- Moderna’s COVID-19 vaccine generates strong immune response in older adults
- Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms
- What makes a great launch leader and launch team?
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Covid-19 redefines rules of customer engagement
- Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs...
- Ongoing Virtual Communication between MSLs and Physicians: a Customer Story
- Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians....
- The concordance conundrum: understanding the complexities of behaviour change
- Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved....
Quick links
Infographics
